Y Cadroy

2.0k total citations
52 papers, 1.5k citations indexed

About

Y Cadroy is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Y Cadroy has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 21 papers in Cardiology and Cardiovascular Medicine and 17 papers in Internal Medicine. Recurrent topics in Y Cadroy's work include Blood Coagulation and Thrombosis Mechanisms (25 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Venous Thromboembolism Diagnosis and Management (17 papers). Y Cadroy is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (25 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Venous Thromboembolism Diagnosis and Management (17 papers). Y Cadroy collaborates with scholars based in France, United States and Norway. Y Cadroy's co-authors include B Boneu, Kjell S. Sakaríassen, Stephen R. Hanson, Piérre Siè, Claire Thalamas, Jean-Pierre Bossavy, D. Dupouy, Luc Sagnard, Laurence A. Harker and LA Harker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Y Cadroy

52 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Y Cadroy 753 712 523 462 237 52 1.5k
G.D.O. Lowe 444 0.6× 365 0.5× 285 0.5× 276 0.6× 396 1.7× 61 1.4k
Giuseppe Cella 399 0.5× 533 0.7× 441 0.8× 428 0.9× 294 1.2× 87 1.4k
Andrew A. Ziskind 766 1.0× 378 0.5× 281 0.5× 414 0.9× 349 1.5× 28 1.3k
Angela L. Bergeron 631 0.8× 512 0.7× 225 0.4× 338 0.7× 191 0.8× 34 1.7k
Luigi Oltrona 1.1k 1.4× 241 0.3× 277 0.5× 354 0.8× 174 0.7× 32 1.4k
L. Eijsman 1.3k 1.7× 495 0.7× 296 0.6× 1.6k 3.5× 283 1.2× 63 3.2k
Shu He 316 0.4× 555 0.8× 250 0.5× 122 0.3× 363 1.5× 42 1.1k
E.J.P. Brommer 267 0.4× 797 1.1× 282 0.5× 421 0.9× 494 2.1× 75 1.7k
J H Chesebro 812 1.1× 155 0.2× 237 0.5× 562 1.2× 237 1.0× 19 1.2k
Shigeki Miyata 336 0.4× 786 1.1× 202 0.4× 498 1.1× 244 1.0× 95 1.7k

Countries citing papers authored by Y Cadroy

Since Specialization
Citations

This map shows the geographic impact of Y Cadroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Cadroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Cadroy more than expected).

Fields of papers citing papers by Y Cadroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Cadroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Cadroy. The network helps show where Y Cadroy may publish in the future.

Co-authorship network of co-authors of Y Cadroy

This figure shows the co-authorship network connecting the top 25 collaborators of Y Cadroy. A scholar is included among the top collaborators of Y Cadroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Cadroy. Y Cadroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barreto, Philipe de Souto, Y Cadroy, Eirini Kelaiditi, Bruno Vellas, & Yves Rolland. (2015). The prognostic value of body-mass index on mortality in older adults with dementia living in nursing homes. Clinical Nutrition. 36(2). 423–428. 19 indexed citations
2.
Bassand, Jean‐Pierre, et al.. (2007). Efficacy and safety of fondaparinux in patients with acute coronary syndromes. Expert Review of Cardiovascular Therapy. 5(6). 1013–1026. 6 indexed citations
3.
Cadroy, Y, Claire Thalamas, Kjell S. Sakaríassen, & B Boneu. (2005). Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers. Thrombosis Research. 116(4). 293–300. 8 indexed citations
4.
Cadroy, Y, Fabien Pillard, Kjell S. Sakaríassen, et al.. (2002). Strenuous but not moderate exercise increases the thrombotic tendency in healthy sedentary male volunteers. Journal of Applied Physiology. 93(3). 829–833. 64 indexed citations
5.
6.
Sakaríassen, Kjell S., Stephen R. Hanson, & Y Cadroy. (2001). Methods and Models to Evaluate Shear-Dependent and Surface Reactivity-Dependent Antithrombotic Efficacy. Thrombosis Research. 104(3). 149–174. 49 indexed citations
7.
Bossavy, Jean-Pierre, Y Cadroy, Kjell S. Sakaríassen, B Boneu, & A Barret. (1999). Nonfractionated Heparin Fails to Inhibit Arterial Thrombosis in a Human Ex Vivo Thrombosis Model. Annals of Vascular Surgery. 13(4). 393–401. 7 indexed citations
8.
Bossavy, Jean-Pierre, Claire Thalamas, Luc Sagnard, et al.. (1998). A Double-Blind Randomized Comparison of Combined Aspirin and Ticlopidine Therapy Versus Aspirin or Ticlopidine Alone on Experimental Arterial Thrombogenesis in Humans. Blood. 92(5). 1518–1525. 61 indexed citations
9.
Cadroy, Y, D. Dupouy, & B Boneu. (1998). Arachidonic Acid Enhances the Tissue Factor Expression of Mononuclear Cells by the Cyclo-Oxygenase-1 Pathway: Beneficial Effect of n-3 Fatty Acids. The Journal of Immunology. 160(12). 6145–6150. 16 indexed citations
10.
Bossavy, Jean-Pierre, Claire Thalamas, Luc Sagnard, et al.. (1998). A Double-Blind Randomized Comparison of Combined Aspirin and Ticlopidine Therapy Versus Aspirin or Ticlopidine Alone on Experimental Arterial Thrombogenesis in Humans. Blood. 92(5). 1518–1525. 1 indexed citations
11.
12.
13.
Diquélou, Armelle, et al.. (1994). Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface. Blood. 84(7). 2206–2213. 42 indexed citations
14.
Cadroy, Y, Piérre Siè, & B Boneu. (1994). Frequency of a defective response to activated protein C in patients with a history of venous thrombosis [letter; comment]. Blood. 83(7). 2008–2009. 30 indexed citations
15.
Cadroy, Y, Stephen R. Hanson, & Laurence A. Harker. (1993). Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(8). 1213–1217. 10 indexed citations
16.
Cadroy, Y, et al.. (1991). Comparison of the fibrinolytic response to 10 minutes venous occlusion in males with and without antecedent of deep vein thrombosis. Thrombosis Research. 64(6). 783–786. 2 indexed citations
17.
Cadroy, Y, John M. Maraganore, Stephen R. Hanson, & Laurence A. Harker. (1991). Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons.. Proceedings of the National Academy of Sciences. 88(4). 1177–1181. 22 indexed citations
18.
Cadroy, Y, R A Houghten, & Stephen R. Hanson. (1989). RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.. Journal of Clinical Investigation. 84(3). 939–944. 36 indexed citations
19.
Cadroy, Y, T. A. Horbett, & Stephen R. Hanson. (1989). Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.. PubMed. 113(4). 436–48. 59 indexed citations
20.
Boneu, B, C. Caranobe, Y Cadroy, et al.. (1988). Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the Rabbit. Seminars in Thrombosis and Hemostasis. 14(1). 18–27. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G.D.O. Lowe Breakdown of academic impact, for papers by Giuseppe Cella Breakdown of academic impact, for papers by Andrew A. Ziskind Breakdown of academic impact, for papers by Angela L. Bergeron Breakdown of academic impact, for papers by Luigi Oltrona Breakdown of academic impact, for papers by L. Eijsman Breakdown of academic impact, for papers by Shu He Breakdown of academic impact, for papers by E.J.P. Brommer Breakdown of academic impact, for papers by J H Chesebro Breakdown of academic impact, for papers by Shigeki Miyata
Rankless by CCL
2026